By Western-blot, we measured the amounts of major factors of both pathways, such as Akt, phosphorylated (p) mTOR, p-p70S6K, IKKα, p-IKKα, p65, and p-p65, in both BC cell lines before and after Everolimus treatment. The gene discussed is AKT1; the disease is breast cancer.